Myasthenia Gravis, Generalized
Also known as: Generalized Myasthenia Gravis / Myasthenia Gravis Generalised
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01257 | Eculizumab | A recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). |
| DB15270 | Efgartigimod alfa | A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive. |
| DB06205 | Hyaluronidase (human recombinant) | An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents. |
| DB11580 | Ravulizumab | A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. |
| DB14919 | Rozanolixizumab | A humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis. |
| DB15636 | Zilucoplan | A complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults. |